Back to today’s briefing

Story perspectives

TB Drug Price Cut Saves $37 Million Annually

4/23/2025

44 11

Summary

Story summary

The Stop TB Partnership's Global Drug Facility has slashed the price of pretomanid, a crucial treatment for multidrug-resistant tuberculosis, by 25%, bringing it down to $169 per course. This significant reduction will save national TB programs around $37 million each year, paving the way for safer and quicker recovery through the innovative BPaLM regimen.

1 of 1

Story summary

The Stop TB Partnership's Global Drug Facility has slashed the price of pretomanid, a crucial treatment for multidrug-resistant tuberculosis, by 25%, bringing it down to $169 per course. This significant reduction will save national TB programs around $37 million each year, paving the way for safer and quicker recovery through the innovative BPaLM regimen.